Form 4: Clorox Executive Kirsten Marriner Reports Acquisition of Common Stock
SEC Form 4 Filing
EVP and Chief People Officer of Clorox, Kirsten Marriner, reports acquiring 5,221 shares of common stock at $164.69 per share.
Summary
- On September 17, 2024, Kirsten Marriner, EVP Chief People Officer of Clorox, acquired 5,221 shares of Clorox common stock at a price of $164.69 per share.
- Following the transaction, Marriner directly owns 31,198 shares of Clorox common stock.
- The acquired securities are Restricted Stock Units that will vest in four equal installments annually from October 5, 2025, to October 5, 2028.
Sentiment
Score: 5
Explanation: The document is a neutral report of a stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the holdings of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding executive stock ownership.
- It aligns executive interests with those of the shareholders through equity ownership.
Key Dates
| Date | Description |
|---|---|
| 09/17/2024 | Date of transaction: Kirsten Marriner acquired 5,221 shares of Clorox common stock. |
| 09/19/2024 | Date of report filing. |
| 10/05/2025 | First vesting date for 1/4 of the Restricted Stock Units. |
| 10/05/2026 | Second vesting date for 1/4 of the Restricted Stock Units. |
| 10/05/2027 | Third vesting date for 1/4 of the Restricted Stock Units. |
| 10/05/2028 | Final vesting date for 1/4 of the Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.